Defu Cai

1.1k total citations
28 papers, 830 citations indexed

About

Defu Cai is a scholar working on Molecular Biology, Biomaterials and Rehabilitation. According to data from OpenAlex, Defu Cai has authored 28 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Biomaterials and 6 papers in Rehabilitation. Recurrent topics in Defu Cai's work include Nanoparticle-Based Drug Delivery (9 papers), Magnolia and Illicium research (6 papers) and Nanoplatforms for cancer theranostics (4 papers). Defu Cai is often cited by papers focused on Nanoparticle-Based Drug Delivery (9 papers), Magnolia and Illicium research (6 papers) and Nanoplatforms for cancer theranostics (4 papers). Defu Cai collaborates with scholars based in China, France and United States. Defu Cai's co-authors include Wenquan Zhu, Qi Zhang, Dan Liu, Jing Wang, Shuang Guan, Cuiyan Han, Xiaoxing Ma, Jianwen Zhou, Jiayi Qian and Guihua Xing and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Scientific Reports.

In The Last Decade

Defu Cai

26 papers receiving 823 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Defu Cai China 16 352 290 218 94 75 28 830
Shiyao Hua China 14 214 0.6× 261 0.9× 151 0.7× 75 0.8× 153 2.0× 24 876
Xiaohui Pu China 19 329 0.9× 272 0.9× 169 0.8× 94 1.0× 209 2.8× 42 844
Cuiyan Han China 16 273 0.8× 284 1.0× 194 0.9× 109 1.2× 105 1.4× 42 734
Ziming Zhao China 21 374 1.1× 333 1.1× 218 1.0× 106 1.1× 145 1.9× 56 1.1k
Ding Qu China 22 512 1.5× 319 1.1× 250 1.1× 128 1.4× 110 1.5× 50 1.2k
Caisheng Wu China 20 388 1.1× 182 0.6× 169 0.8× 33 0.4× 47 0.6× 54 987
Yue Sun China 22 560 1.6× 219 0.8× 472 2.2× 151 1.6× 95 1.3× 77 1.4k
Ju Liang China 16 348 1.0× 181 0.6× 124 0.6× 75 0.8× 29 0.4× 52 720
Andreia Granja Portugal 14 260 0.7× 221 0.8× 171 0.8× 94 1.0× 128 1.7× 23 845
Ravinder Verma India 14 207 0.6× 209 0.7× 166 0.8× 131 1.4× 212 2.8× 61 835

Countries citing papers authored by Defu Cai

Since Specialization
Citations

This map shows the geographic impact of Defu Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Defu Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Defu Cai more than expected).

Fields of papers citing papers by Defu Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Defu Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Defu Cai. The network helps show where Defu Cai may publish in the future.

Co-authorship network of co-authors of Defu Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Defu Cai. A scholar is included among the top collaborators of Defu Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Defu Cai. Defu Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Dan, Qiyue Zhang, Liang Wang, et al.. (2025). Targeting the CD44 receptor with hyaluronic acid-modified SWCNTs for 17-hydroxy-jolkinolide B delivery to inhibit breast cancer metastasis. International Journal of Biological Macromolecules. 310(Pt 3). 143260–143260.
2.
Wang, Jing, Xueying Yan, Wenfei Wang, et al.. (2025). Rab21-Targeted Nano Drug Delivery System-Based FFPG for Efficient Paclitaxel Delivery to Inhibit Lung Cancer Progression. Pharmaceutics. 17(1). 94–94.
3.
Wang, Wenbao, Yufang Wang, Defu Cai, et al.. (2024). The Graphene Quantum Dots Gated Nanoplatform for Photothermal-Enhanced Synergetic Tumor Therapy. Molecules. 29(3). 615–615. 14 indexed citations
4.
Fan, Dejun, et al.. (2024). Targeted delivery of rhein via hyaluronic acid modified liposomes for suppression of growth and metastasis of breast cancer. International Journal of Biological Macromolecules. 282(Pt 5). 137105–137105. 5 indexed citations
6.
Ma, Xiaoxing, Xiaoyu Sui, Chang Liu, et al.. (2023). Co-delivery of berberine and magnolol targeted liposomes for synergistic anti-lung cancer. Colloids and Surfaces A Physicochemical and Engineering Aspects. 673. 131773–131773. 15 indexed citations
7.
Zhang, Qi, Dong Li, Shuang Guan, et al.. (2022). Tumor-targeted delivery of honokiol via polysialic acid modified zein nanoparticles prevents breast cancer progression and metastasis. International Journal of Biological Macromolecules. 203. 280–291. 28 indexed citations
8.
Li, Gang, Ke Jiang, Tao Xu, et al.. (2022). Customized multi-stimuli nanovehicles with dissociable ‘bomblets’ for photothermal-enhanced synergetic tumor therapy. Colloids and Surfaces B Biointerfaces. 222. 113083–113083. 2 indexed citations
9.
Liu, Dan, Qi Zhang, Jing Wang, et al.. (2021). Inhibition of growth and metastasis of breast cancer by targeted delivery of 17-hydroxy-jolkinolide B via hyaluronic acid-coated liposomes. Carbohydrate Polymers. 257. 117572–117572. 32 indexed citations
10.
Wang, Jing, Dan Liu, Shuang Guan, et al.. (2020). Hyaluronic acid-modified liposomal honokiol nanocarrier: Enhance anti-metastasis and antitumor efficacy against breast cancer. Carbohydrate Polymers. 235. 115981–115981. 92 indexed citations
11.
Cai, Defu, Cuiyan Han, Chang Liu, et al.. (2020). Chitosan-capped enzyme-responsive hollow mesoporous silica nanoplatforms for colon-specific drug delivery. Nanoscale Research Letters. 15(1). 123–123. 52 indexed citations
13.
Liu, Dan, Qi Zhang, Jing Wang, et al.. (2019). Hyaluronic acid-coated single-walled carbon nanotubes loaded with doxorubicin for the treatment of breast cancer.. PubMed. 74(2). 83–90. 38 indexed citations
14.
Li, Jiping, Defu Cai, Liling Yue, et al.. (2018). Anticancer Efficacy of Targeted Shikonin Liposomes Modified with RGD in Breast Cancer Cells. Molecules. 23(2). 268–268. 43 indexed citations
16.
Zhu, Wenquan, Hong Guan, Han Liu, et al.. (2016). Development of a matrix solid-phase dispersion extraction combined with high-performance liquid chromatography for determination of five lignans from the Schisandra chinensis. Journal of Chromatography B. 1011. 151–157. 27 indexed citations
17.
Cai, Defu, Wei Gao, Bing He, et al.. (2013). Hydrophobic penetrating peptide PFVYLI-modified stealth liposomes for doxorubicin delivery in breast cancer therapy. Biomaterials. 35(7). 2283–2294. 88 indexed citations
19.
Xing, Guihua, Miaoxian Dong, Xiaoming Li, et al.. (2011). Neuroprotective effects of puerarin against beta-amyloid-induced neurotoxicity in PC12 cells via a PI3K-dependent signaling pathway. Brain Research Bulletin. 85(3-4). 212–218. 79 indexed citations
20.
Cai, Defu, Qi Zhang, & Jianhua Liu. (2011). SIMULTANEOUS DETERMINATION OF PAEONOL AND FERULIC ACID IN SU-XIAO-XIN-TONG DROPPING PILLS BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY WITH MATRIX SOLID-PHASE DISPERSION EXTRACTION. Journal of Liquid Chromatography & Related Technologies. 34(17). 1825–1837. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026